Data Drug Development Leadership Life Science 
Digital Health Global
MARCH 2, 2023
Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.
Lloyd Price
FEBRUARY 18, 2024
Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
JANUARY 23, 2024
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,
Digital Health Global
JUNE 20, 2023
These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,
Healthcare IT Today
JANUARY 17, 2024
As behavioral health practitioners, we must make our voices heard from the very beginning of the generative AI conversation to bring the evidence-based data and experience to the conversation. Embrace the value while protecting the data. It is all too easy for non-clinicians to bear on what is a therapeutic clinical experience.
Expert insights. Personalized for you.
88 
Let's personalize your content